The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yang, I Ping ^a,b   Tsai, Hsiang Lin ^a,c   Huang, Ching Wen ^a,c,d   Huang, Ming Yii ^a,c   Hou, Ming Feng ^a,c   Juo, Suh Hang Hank ^a,c   Wang, Jaw Yuan ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b SHU ZEN JUNIOR COLLEGE OF MEDICINE AND MANAGEMENT   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29; MICRORNA 29C; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CACO-2 CELLS; CASE-CONTROL STUDIES; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; TREATMENT FAILURE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

MUS;

EID: 84879543880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066842     Document Type: Article

References (34)

1. Boyle P, Leon ME, (2002) Epidemiology of colorectal cancer. Br Med Bull 64: 1-25.
2. Becker H, (1995) [Surgery of colorectal carcinoma]. Praxis (Bern 1994) 84: 1371-1372.
3. Tsai HL, Yeh YS, Yu FJ, Lu CY, Chen CF, et al. (2009) Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes. Int J Colorectal Dis 24: 177-183.
4. Longo WE, Johnson FE, (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82: 1091-1108.
5. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, et al. (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 141: 67-75.
6. Davous D, (2009) [French support organisations for young cancer patients and their families]. Bull Acad Natl Med 193: 1529-1541.
7. Yang IP, Tsai HL, Hou MF, Chen KC, Tsai PC, et al. (2012) MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis 33: 1522-1530.
8. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
9. Cho WC, (2010) MicroRNAs in cancer- from research to therapy. Biochim Biophys Acta 1805: 209-217.
10. Cho WC, (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281.
11. Cao D, Hou M, Guan YS, Jiang M, Yang Y, et al. (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9: 432.
12. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
13. Nugent M, Miller N, Kerin MJ (2012) Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol.
14. Wang LG, Gu J, (2012) Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 36: e61-67.
15. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
16. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
17. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
18. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, et al. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59.
19. Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY, et al. (2012) Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One 7: e31587.
20. Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, et al. (2009) Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 100: 736-743.
21. Yang IP, Tsai HL, Hou MF, Chen KC, Tsai PC, et al. (2012) MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis.
22. Burfeind P, Chernicky CL, Rininsland F, Ilan J, (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci U S A 93: 7263-7268.
23. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2012) Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386.
24. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, et al. (2008) Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405.
25. Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, et al. (2009) miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 23: 1159-1163.
26. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
27. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, et al. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135.
28. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
29. Retraction notice to "Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes" [Biochem. Biophys. Res. Commun. 364 (2007) 937-944]. Biochem Biophys Res Commun 413: 649.
30. Kumar M, Lu Z, Takwi AA, Chen W, Callander NS, et al. (2011) Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30: 843-853.
31. Park SY, Lee JH, Ha M, Nam JW, Kim VN, (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29.
32. Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J, et al. (2011) miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 32: 1025-1032.
33. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, et al. (2008) MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A 105: 5874-5878.
34. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805-15810.